You are here: Industry Insights > J&J

News List

J&J single-dose COVID-19 vaccine gets approval for EUA in India expresspharma
August 09, 2021
The single-shot vaccine in clinical trials proved to be 85 per cent effective in preventing COVID-19, and also showed protection against COVID-19 related hospitalisation and death.
India approves J&J vaccine; no delivery timeline yet firstwordpharma
August 09, 2021
India health minister Mansukh Mandaviya said the country has approved Johnson & Johnson's COVID-19 vaccine for emergency use, but the company said it was too early to give a delivery timeline, as reported This is Money.
J&J committed to bring its COVID jab to India after withdrawing proposal expresspharma
August 04, 2021
Johnson & Johnson August 2 said it remains committed to bring its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.
J&J's 2Q Pharma Sales Up 17% contractpharma
July 30, 2021
STELARA and DARZALEX sales drive growth with sales up 34% to $2.3 billion and up 59% to $1.4 billion in the quarter, respectively.
J&J to pay up to $5bn in US opioid settlement europeanpharmaceuticalreview
July 28, 2021
Johnson & Johnson has signed a nationwide opioid settlement agreement and will pay billions to settle opioid-related claims and litigation in the US.
Johnson & Johnson reports 27.1% increase in Q2 2021 sales pharmaceutical-technology
July 23, 2021
Johnson & Johnson (J&J) has reported sales of $23.31bn in the second quarter (Q2) of 2021, an increase of 27.1% compared to $18.33bn in the same quarter last year.
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine drugs
July 13, 2021
The U.S. Food and Drug Administration issued a new warning for the Johnson & Johnson COVID-19 vaccine that says the shot has been tied to Guillain-Barré syndrome.
J&J Vaccine Guards Against Delta Variant, Company Says drugs
July 05, 2021
Johnson & Johnson announced Thursday that its COVID-19 vaccine is effective against the highly contagious Delta variant that brought India to its knees this past spring.
J&J ends sales of opioids in the US, reaches settlement deal with New York firstwordpharma
June 28, 2021
Johnson & Johnson disclosed alongside a settlement agreement with the State of New York that it stopped selling prescription pain medicines in the US last year, having ceased marketing of the products in 2015.
U.S. Sends 3 Million J&J COVID-19 Vaccine Doses to Brazil drugs
June 25, 2021
The United States is sending 3 million doses of the Johnson & Johnson' COVID-19 vaccine to Brazil, as that country struggles with a surge in cases and its death toll climbs above 500,000.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page